What is VNT's health score?

Vontier Corp (VNT) has a TradeApes health score of 58 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is VNT's estimated fair value?

Based on our 5-year discounted cash flow model, Vontier Corp's estimated fair value is $17.08 per share, representing a -43.7% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is VNT undervalued or overvalued?

Our model currently rates VNT as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

3 free score cards remaining

Vontier Corp (VNT)

Healthcare Overvalued high mixed

$30.35

Updated: 2026-07-18

TradeApes Score

Financial Strength

50 Mixed

Operating Trend

55 Mixed

Relative Value

75 Strong

Capital Allocation

55 Mixed

Risk Management

50 Mixed

Est. Fair Value $17.08

DCF Upside -43.7%

Sector Rank #5873 of 12118

Key Findings

+ High FCF yield — above 7%, strong cash return relative to price paid

Unlock Full Report →

− High leverage — net debt/EBITDA between 3× and 5×

Unlock Full Report →

Industry Related Stocks

AGILENT TECHNOLOGIES, INC. (A) ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) Aardvark Therapeutics, Inc. (AARD) AUTOSCOPE TECHNOLOGIES CORP (AATC) Abivax S.A. (AAVXF) Ascend Wellness Holdings, Inc. (AAWH)

See all Healthcare stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.